FibroBiologics Inc. Commo...
1.98
0.10 (5.32%)
At close: Jan 15, 2025, 3:59 PM
2.02
2.02%
After-hours Jan 15, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue 437.00K 94.00K n/a n/a
Gross Profit -437.00K -94.00K n/a n/a
Operating Income -8.89M -4.47M -1.58M -1.17M
Interest Income n/a n/a n/a n/a
Pretax Income -16.48M -5.12M -1.58M -1.17M
Net Income -16.48M -5.12M -1.58M -1.17M
Selling & General & Admin 6.52M 3.23M 1.06M 500.00K
Research & Development 2.37M 1.15M 521.00K 669.00K
Other Expenses n/a n/a n/a n/a
Operating Expenses 8.89M 4.37M 1.58M 1.17M
Interest Expense 147.00K 654.00K 4.00K n/a
Selling & Marketing Expenses 685.00K -94.00K n/a n/a
Cost & Expenses 8.89M 4.47M 1.58M 1.17M
Income Tax n/a n/a n/a n/a
Shares Outstanding (Basic) 32.49M 32.49M 32.49M 8.75M
Shares Outstanding (Diluted) 28.23M 32.49M 32.49M 8.75M
EPS (Basic) -0.59 -0.16 -0.05 -0.13
EPS (Diluted) -0.68 -0.16 -0.05 -0.13
EBITDA -15.90M -4.37M -1.58M n/a
Depreciation & Amortization 437.00K 94.00K n/a 1.17M